Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...

The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.

Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...

Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with ...

Robert F. Kennedy Jr., Trump's pick​ to lead the Department of Health and Human Services, has raised controversy on topics ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.

A groundbreaking medication designed to delay the onset of Alzheimer's has received approval for use within the EU. The drug, ...

With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an ...

A possible breakthrough has been made in slowing the effects of Alzheimer’s in the form of a drug currently undergoing ...

Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for review the resubmission of the supplemental Biologics License ...